Patients suffering from prolonged symptoms of inflammatory bowel disease (IBD) are commonly grouped as having ‘difficult-to-treat IBD’ that requires ongoing and particular treatment approaches. Until now, there has been no standard set of definitions around this which has hampered research and therapeutic strategies.